ArticleFrontiers in pharmacology2021

Aberrant ROS Mediate Cell Cycle and Motility in Colorectal Cancer Cells Through an Oncogenic CXCL14 Signaling Pathway.

Jun Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.